See the DrugPatentWatch profile for Ziprasidone
Ziprasidone is indicated for the treatment of schizophrenia in adults [1]. It is also used for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults and in pediatric patients aged 10 years and older [1].
What is ziprasidone used for in children?
In pediatric patients aged 10 years and older, ziprasidone is approved for the acute treatment of manic or mixed episodes associated with bipolar I disorder [1].
How does ziprasidone work?
Ziprasidone is an atypical antipsychotic that works by affecting the activity of certain neurotransmitters in the brain, primarily dopamine and serotonin [1]. Its precise mechanism of action in treating schizophrenia and bipolar disorder is not fully understood [1].
What are the potential side effects of ziprasidone?
Common side effects of ziprasidone can include drowsiness, dizziness, nausea, vomiting, constipation, and headache [1]. More serious side effects may include changes in heart rhythm, tardive dyskinesia, and neuroleptic malignant syndrome [1].
When does ziprasidone's patent expire?
Information on the patent expiry for ziprasidone can be found on DrugPatentWatch.com [2]. Patent protection dates are crucial for understanding when generic versions of a drug may become available.
Are there alternative treatments for schizophrenia and bipolar disorder?
Yes, there are other antipsychotic medications available for treating schizophrenia and bipolar disorder, including other atypical antipsychotics and older typical antipsychotics [3]. Treatment choice often depends on individual patient factors, response to medication, and side effect profiles [3].
---
Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020715s030,021943s009,021791s023lbl.pdf
2. https://drugpatentwatch.com/
3. https://www.nimh.nih.gov/health/topics/schizophrenia